These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33632140)

  • 1. Monitoring HIV testing and pre-exposure prophylaxis information seeking by combining digital and traditional data.
    Johnson DC; Nobles AL; Caputi TL; Liu M; Leas EC; Strathdee SA; Smith DM; Ayers JW
    BMC Infect Dis; 2021 Feb; 21(1):215. PubMed ID: 33632140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Search Engine Data to Explore Interest in PrEP and HIV Testing in the United States.
    Whiteman A; Wejnert C; Morris E; Burnett J
    AIDS Behav; 2021 Mar; 25(3):983-991. PubMed ID: 33033997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
    Siegler AJ; Mehta CC; Mouhanna F; Giler RM; Castel A; Pembleton E; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Sullivan PS
    Ann Epidemiol; 2020 May; 45():24-31.e3. PubMed ID: 32336655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to PrEP and other sexual health services for cisgender women in the United States: a review of state policy and Medicaid expansion.
    Chory A; Bond K
    Front Public Health; 2024; 12():1360349. PubMed ID: 38983260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.
    Siegler AJ; Mouhanna F; Giler RM; Weiss K; Pembleton E; Guest J; Jones J; Castel A; Yeung H; Kramer M; McCallister S; Sullivan PS
    Ann Epidemiol; 2018 Dec; 28(12):841-849. PubMed ID: 29983236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Social Support in HIV Testing and PrEP Awareness among Young Black Men and Transgender Women Who Have Sex with Men or Transgender Women.
    Lelutiu-Weinberger C; Wilton L; Koblin BA; Hoover DR; Hirshfield S; Chiasson MA; Nandi V; Usher D; Frye V
    J Urban Health; 2020 Oct; 97(5):715-727. PubMed ID: 31898199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of HIV pre-exposure prophylaxis (PrEP) and HIV testing among publicly insured adolescents and young adults (AYA) receiving medication for opioid use disorder (MOUD).
    Herrera MC; Johnson J; Lim S; Morales KH; Wilson JD; Hadland SE; Metzger D; Wood S; Dowshen N
    Drug Alcohol Depend; 2024 Apr; 257():111132. PubMed ID: 38387256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State health policies and interest in PrEP: evidence from Google Trends.
    Farkhad BF; Nazari M; Chan MS; Albarracín D
    AIDS Care; 2022 Mar; 34(3):331-339. PubMed ID: 34191662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.
    Mayer KH; Agwu A; Malebranche D
    Adv Ther; 2020 May; 37(5):1778-1811. PubMed ID: 32232664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.
    Chan SS; Chappel AR; Maddox KEJ; Hoover KW; Huang YA; Zhu W; Cohen SM; Klein PW; De Lew N
    PLoS Med; 2020 Apr; 17(4):e1003072. PubMed ID: 32275654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling Study.
    Goodreau SM; Hamilton DT; Jenness SM; Sullivan PS; Valencia RK; Wang LY; Dunville RL; Barrios LC; Rosenberg ES
    J Adolesc Health; 2018 Mar; 62(3):311-319. PubMed ID: 29248392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Evaluation of a Mobile App Designed to Increase HIV Testing and Pre-exposure Prophylaxis Use Among Young Men Who Have Sex With Men in the United States: Open Pilot Trial.
    Biello KB; Hill-Rorie J; Valente PK; Futterman D; Sullivan PS; Hightow-Weidman L; Muessig K; Dormitzer J; Mimiaga MJ; Mayer KH
    J Med Internet Res; 2021 Mar; 23(3):e25107. PubMed ID: 33759792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012-2016.
    Smith DK; Sullivan PS; Cadwell B; Waller LA; Siddiqi A; Mera-Giler R; Hu X; Hoover KW; Harris NS; McCallister S
    Clin Infect Dis; 2020 Dec; 71(12):3144-3151. PubMed ID: 32097453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to HIV Pre-Exposure Prophylaxis Testing Guidelines in the United States.
    McCormick CD; Sullivan PS; Qato DM; Crawford SY; Schumock GT; Lee TA
    AIDS Patient Care STDS; 2023 Jul; 37(7):337-350. PubMed ID: 37204299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
    Sevelius JM; Poteat T; Luhur WE; Reisner SL; Meyer IH
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):437-442. PubMed ID: 32692101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States.
    Siegler AJ; Bratcher A; Weiss KM; Mouhanna F; Ahlschlager L; Sullivan PS
    Ann Epidemiol; 2018 Dec; 28(12):858-864. PubMed ID: 30406756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographics, Trends, and Clinical Characteristics of HIV Pre-Exposure Prophylaxis Recipients and People Newly Diagnosed with HIV from Large Electronic Health Records in Florida.
    Liu Y; Siddiqi KA; Cho H; Park H; Prosperi M; Cook RL
    AIDS Patient Care STDS; 2024 Jan; 38(1):14-22. PubMed ID: 38227279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
    Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
    Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.
    Sullivan PS; Giler RM; Mouhanna F; Pembleton ES; Guest JL; Jones J; Castel AD; Yeung H; Kramer M; McCallister S; Siegler AJ
    Ann Epidemiol; 2018 Dec; 28(12):833-840. PubMed ID: 30037634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.